142 related articles for article (PubMed ID: 1928036)
1. Comparison of different measurements of intestinal permeability in inflammatory bowel disease.
Howden CW; Robertson C; Duncan A; Morris AJ; Russell RI
Am J Gastroenterol; 1991 Oct; 86(10):1445-9. PubMed ID: 1928036
[TBL] [Abstract][Full Text] [Related]
2. Comparison between lactulose-mannitol test and 51Cr-labelled ethylene diamine tetra-acetate test in inflammatory bowel diseases.
Andre C; Descos L; Minaire Y
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():113-7. PubMed ID: 2128072
[TBL] [Abstract][Full Text] [Related]
3. Increased intestinal permeability in patients with inflammatory bowel disease.
Welcker K; Martin A; Kölle P; Siebeck M; Gross M
Eur J Med Res; 2004 Oct; 9(10):456-60. PubMed ID: 15546811
[TBL] [Abstract][Full Text] [Related]
4. Measurement of intestinal permeability using 51Cr-EDTA.
Peled Y; Watz C; Gilat T
Am J Gastroenterol; 1985 Oct; 80(10):770-3. PubMed ID: 3929593
[TBL] [Abstract][Full Text] [Related]
5. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
[TBL] [Abstract][Full Text] [Related]
6. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
[TBL] [Abstract][Full Text] [Related]
7. [Intestinal permeability in relatives of patients with Crohn's disease].
Kohout P; Koref P
Vnitr Lek; 2001 Jun; 47(6):371-4. PubMed ID: 11494882
[TBL] [Abstract][Full Text] [Related]
8. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease.
Issenman RM; Jenkins RT; Radoja C
Clin Invest Med; 1993 Jun; 16(3):187-96. PubMed ID: 8365046
[TBL] [Abstract][Full Text] [Related]
9. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.
Jenkins RT; Jones DB; Goodacre RL; Collins SM; Coates G; Hunt RH; Bienenstock J
Am J Gastroenterol; 1987 Nov; 82(11):1159-64. PubMed ID: 3118697
[TBL] [Abstract][Full Text] [Related]
10. Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.
Jenkins RT; Ramage JK; Jones DB; Collins SM; Goodacre RL; Hunt RH
Clin Invest Med; 1988 Apr; 11(2):151-5. PubMed ID: 3135136
[TBL] [Abstract][Full Text] [Related]
11. Intestinal permeability in patients with Crohn's disease and their first-degree relatives.
Howden CW; Gillanders I; Morris AJ; Duncan A; Danesh B; Russell RI
Am J Gastroenterol; 1994 Aug; 89(8):1175-6. PubMed ID: 8053430
[TBL] [Abstract][Full Text] [Related]
12. Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine.
Bours MJ; Troost FJ; Brummer RJ; Bast A; Dagnelie PC
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):245-50. PubMed ID: 17301652
[TBL] [Abstract][Full Text] [Related]
13. Intestinal permeability test as a predictor of clinical course in Crohn's disease.
D'Incà R; Di Leo V; Corrao G; Martines D; D'Odorico A; Mestriner C; Venturi C; Longo G; Sturniolo GC
Am J Gastroenterol; 1999 Oct; 94(10):2956-60. PubMed ID: 10520851
[TBL] [Abstract][Full Text] [Related]
14. Is an increased intestinal permeability a valid predictor of relapse in Crohn disease?
Jørgensen J; Ranløv PJ; Bjerrum PJ; Diemer H; Bisgaard K; Elsborg L
Scand J Gastroenterol; 2001 May; 36(5):521-7. PubMed ID: 11346207
[TBL] [Abstract][Full Text] [Related]
15. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man.
Elia M; Behrens R; Northrop C; Wraight P; Neale G
Clin Sci (Lond); 1987 Aug; 73(2):197-204. PubMed ID: 3115663
[TBL] [Abstract][Full Text] [Related]
17. Increased gastric and intestinal permeability in patients with Crohn's disease.
Wyatt J; Oberhuber G; Pongratz S; Püspök A; Moser G; Novacek G; Lochs H; Vogelsang H
Am J Gastroenterol; 1997 Oct; 92(10):1891-6. PubMed ID: 9382060
[TBL] [Abstract][Full Text] [Related]
18. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
19. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
[TBL] [Abstract][Full Text] [Related]
20. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
